Home
>
National Drug Code (NDC)
>
Akne-mycin
Akne-mycin - 13548-030-25 - (erythromycin)
Drug Information of Akne-mycin
| Product NDC: | 13548-030 |
| Proprietary Name: | Akne-mycin |
| Non Proprietary Name: | erythromycin |
| Active Ingredient(s): | 20 mg/g & nbsp; erythromycin |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Akne-mycin
| Product NDC: | 13548-030 |
| Labeler Name: | CORIA LABORATORIES |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050584 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19850110 |
Package Information of Akne-mycin
| Package NDC: | 13548-030-25 |
| Package Description: | 25 g in 1 TUBE (13548-030-25) |
NDC Information of Akne-mycin
| NDC Code | 13548-030-25 |
| Proprietary Name | Akne-mycin |
| Package Description | 25 g in 1 TUBE (13548-030-25) |
| Product NDC | 13548-030 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | erythromycin |
| Dosage Form Name | OINTMENT |
| Route Name | TOPICAL |
| Start Marketing Date | 19850110 |
| Marketing Category Name | NDA |
| Labeler Name | CORIA LABORATORIES |
| Substance Name | ERYTHROMYCIN |
| Strength Number | 20 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
